New phase 3b trial results show Lilly’s Trulicity has helped type 2 diabetes patients already taking an SGLT2 inhibitor but whose blood sugar was inadequately controlled. The AWARD trial showed ...

Trulicity (dulaglutide) grew more than expected to reach $1.2 billion in the period, a rise of 31% that came despite pricing pressure in the US and competition from Novo Nordisk’s rival once ...

You signed in with another tab or window. Reload to refresh your session. You signed out in another tab or window. Reload to refresh your session. You switched accounts on another tab or window.

Wegovy and Trulicity. Its latest earnings report Tuesday showed that first-quarter revenue declined 10% while its loss on an adjusted basis totaled 47 cents per share. However, clinical ...